97 filings
8-K
VRNA
Verona Pharma Plc
9 May 24
Verona Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update
7:22am
8-K
VRNA
Verona Pharma Plc
9 May 24
Verona Pharma Announces $650 Million Strategic Financing with Oaktree and OMERS
7:18am
8-K
VRNA
Verona Pharma Plc
30 Apr 24
Submission of Matters to a Vote of Security Holders
4:11pm
8-K
VRNA
Verona Pharma Plc
29 Feb 24
Verona Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
6:08am
8-K
VRNA
Verona Pharma Plc
2 Feb 24
Departure of Directors or Certain Officers
6:02am
8-K
uh12jkay56boamn32mct
2 Jan 24
Strengthens financial flexibility to support the Company’s continued growth
6:02am
8-K
32umcf2ngvlr ex
18 Dec 23
Changes in Registrant's Certifying Accountant
4:15pm
8-K
6eq1tzyvpw 5ei
2 Nov 23
Verona Pharma Reports Third Quarter 2023 Financial Results and Provides Corporate Update
6:24am
8-K
nfjccw
11 Sep 23
Other Events
6:02am
8-K
195tz
1 Sep 23
Entry into a Material Definitive Agreement
4:05pm
8-K
gf5t sky8yfhrv
3 Aug 23
Verona Pharma Reports Second Quarter 2023 Financial Results and Provides Corporate Update
6:11am
8-K
ppa47qau2tyx1 uilhl
9 May 23
Verona Pharma Reports First Quarter 2023 Financial Results and Provides Corporate Update
6:13am
8-K
dy9v9r9 f711jp1l
1 May 23
Departure of Directors or Certain Officers
5:21pm
8-K
apbodpnhbe kgd
7 Mar 23
Verona Pharma Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
6:06am
8-K
se4 qnf971ihq
20 Dec 22
Regulation FD Disclosure
6:02am
8-K
01jbbyhzfc
9 Nov 22
Verona Pharma Reports Third Quarter 2022 Financial Results and Provides Corporate Update
6:35am
8-K
ivbjr4dp qgr
17 Oct 22
Entry into a Material Definitive Agreement
6:00am
8-K
wwf5eupfaw
11 Aug 22
Other Events
5:46pm
8-K
p361ivnczxxi
9 Aug 22
Verona Pharma Reports Second Quarter 2022 Financial Results and Provides Corporate Update
8:17am
8-K
2p95vij
3 May 22
Verona Pharma Reports First Quarter 2022 Financial Results and Provides Corporate Update
6:11am